Abstract Podocytes are significant in establishing the glomerular filtration barrier. Sustained rennin-angiotensin system (RAS) activation is crucial in the pathogenesis of podocyte injury and causes proteinuria. This study demonstrates that angiotensin II (Ang II) caused a reactive oxygen species (ROS)-dependent rearrangement of cortical F-actin and a migratory phenotype switch in cultured mouse podocytes with stable Ang II type 1 receptor (AT1R) expression. Activated small GTPase Rac-1 and phosphorylated ezrin/radixin/moesin (ERM) proteins provoked Ang II-induced F-actin cytoskeletal remodeling. This work also shows increased expression of Rac-1 and phosphorylated ERM proteins in cultured podocytes, and in glomeruli of podocyte-specific AT1R transgenic rats (Neph-hAT1 TGRs). The free radical scavenger DMTU eliminated Ang II-induced cell migration, ERM protein phosphorylation and cortical F-actin remodeling, indicating that ROS mediates the influence of Rac-1 on podocyte AT1R signaling. Heparin, a potent G-coupled protein kinase 2 inhibitor, was found to abolish ERM protein phosphorylation and cortical F-actin ring formation in Ang II-treated podocytes, indicating that phosphorylated ERM proteins are the cytoskeletal effector in AT1R signaling. Moreover, Ang II stimulation triggered down-regulation of α actinin-4 and reduced focal adhesion expression in podocytes. Signaling inhibitor assay of Ang II-treated podocytes reveals that Rac-1, RhoA, and F-actin reorganization were involved in expressional regulation of α actinin-4 in AT1R signaling. With persistent RAS activation, the Ang IIinduced phenotype shifts from being dynamically stable to adaptively migratory, which may eventually exhaust podocytes with a high actin cytoskeletal turnover, causing podocyte depletion and focal segmental glomerulosclerosis.
balance under physiological conditions. Simultaneously, the RAS is also involved in the pathogenesis and progression of renal diseases [1] . Convincing evidence exists of the direct regulatory effect of angiotensin II (Ang II), the biological effector of the RAS, on the function of glomerular podocytes [2] [3] [4] , which play a crucial role in establishing renal filtration barrier permselectivity [5, 6] . Proteinuria, primarily caused by podocyte injury and consequent filtration barrier failure, predicts progression and renal outcomes in human glomerular diseases. The beneficial effects of RAS blockage on proteinuria reduction, whether occurring via angiotensinconverting enzyme inhibitors (ACEI) or Ang II type 1 receptor (AT1R) antagonists, are confirmed by clinical evidences [1] . Additionally, podocyte-specific overexpression of AT1R (nephrin promoter-driven human AT1R transgenic rats, (Neph-hAT1 TGR)) causes proteinuria, glomerular damage, and glomerulosclerosis [7] , confirming the crucial role of the RAS in the pathogenesis of podocyte injury and proteinuria development. Mediated by AT1Rs, Ang II can induce various cellular effects, such as contraction, migration, cell growth or hypertrophy, via different signaling pathways [8] . Furthermore, expression of angiotensin receptors is increased in proteinuric renal diseases [6] . However, the signaling mechanisms of Ang II on podocytes remain obscure.
The actin cytoskeleton of the podocyte is important in regulating the tentacle structure of the podocyte foot process and the filtration slit diaphragm [9] , and also helps counteract the expansion of glomerular capillaries in response to varied blood pressure gradients [5] . Realizing this goal requires an intact podocyte cytoskeleton, intact cytoskeletal connections to the slit diaphragm (podocyte cytoskeleton connects to the slit diaphragm and the glomerular basement membrane both) and the glomerular basement membrane, and adequate regulatory responses to any hemodynamic challenges. Previous research has identified two distinct forms of actin cytoskeleton in podocytes: F-actin bundles running along the longitudinal axis of foot processes above the slit diaphragm and a cortical actin network located beneath the plasma membrane of the foot process [5] . The F-actin cytoskeleton in podocyte foot processes is believed to be dynamically maintained with steady-state and low turnover [9] . Foot process effacement, a characteristic morphologic change of podocytes in proteinuric renal diseases, results from actin cytoskeletal rearrangement following injury [10, 11] . Ang II induces reorganization of F-actin fibers and redistribution of zonula occludens-1 (ZO-1) protein in cultured podocytes [12] . However, the mechanisms causing dynamic change of actin cytoskeleton in podocytes are poorly understood. This work thus investigates the signaling mechanisms of Ang IImediated regulation of F-actin cytoskeletal organization in podocytes.
Materials and methods

Chemicals
Losartan potassium was a gift from Merk & Co., Inc. under material transfer agreement No. 34301. Angiotensin II (A9525), PD123319 (P186), and dimethylthiourea (DMTU, D18870) were purchased from Sigma-Aldrich. SCH51344 (#553509), Y27632 (#688001), SB203580 (#559398), and calphostin C (#208725) were purchased from Calbiochem. Finally, heparin was purchased from Ratiopharm.
Cell culture
A recently generated conditionally immortalized mouse podocyte cell line was cultivated as described elsewhere [13] . Briefly, podocytes were maintained in RPMI 1640 medium (PAA, Cölbe, Germany) supplemented with 10% fetal bovine serum (FBS) (Biochrom, Berlin, Germany) in a humidified atmosphere of 5% CO 2 . To stimulate podocyte proliferation, cells were cultivated at 33°C (permissive conditions) in a culture medium supplemented with 10 U/ ml mouse recombinant γ-interferon (Roche, Mannheim, Germany) to induce expression of temperature-sensitive large T antigen. To induce differentiation, podocytes were maintained at 38°C without γ-interferon (nonpermissive conditions) for at least 2 weeks. HEK293 cells were cultured in DMEM (PAA, Cölbe, Germany) supplemented with 10% FBS. All cells were FBS-deprived for 24 h before each experiment. For immunofluorescence studies and intracellular Ca 2+ measurements, podocytes were seeded on glass coverslips pre-coated with a solution of 0.1 mg/ml mouse collagen (Biochrom, Berlin, Germany) for 30 min at room temperature. To observe living cells, podocytes were cultivated in a 25 cm 2 culture flask with a plug seal cap (BD Falcon).
Experimental animals
All animal experiments were conducted using podocytespecific human AT1R transgenic rats (Neph-hAT1 TGRs) and age-matched wild-type littermates [7] . Briefly, the TGRs were generated by microinjecting a 3.5-kb transgene (NephhAT1) containing a 1.25-kb fragment of human nephrin promoter (Neph) and a 1.4-kb fragment of human AT1R cDNA (hAT1) into the pronuclei of fertilized oocytes of Sprague-Dawley rats. Use of the nephrin promoter to target glomerular podocytes resulted in a rough doubling of AT1R signaling throughout the lifespan of the animals. All male TGRs developed significant albuminuria from 8 to 15 weeks of age and glomerular structural changes occurred concurrently, first ubiquitous formation of pseudocysts, followed by foot process effacement and local detachment of podocytes.
Finally, this damage progressed to nephron loss via the typical and well-known pathway of classic FSGS.
The experimental rats were maintained on a 12-h lightdark cycle with 55% humidity at an ambient temperature of 23±2°C and with an uncontrolled standard pellet diet (Ssniff, Soest, Germany) and tap water. Glomeruli and tubuli were isolated from rat kidneys via sequential sieving as described previously [7] . All studies were approved by the institutional animal care review committee and performed according to government regulations.
Generation of AT1R podocytes
Retroviral gene delivery was performed as described elsewhere [14] . The plasmid pLXSN was kindly provided by D. Miller (Fred Hutchinson Cancer Research Center, Seattle, WA, USA). The pMD-G and pMD-gp plasmids were kindly provided by R. Mulligan (Harvard Medical School, Boston, MA, USA). A 1.1-kb fragment of the hAT1R cDNA containing the entire coding region (gifted by T. Inagami, Vanderbilt University School of Medicine, Nashville, Tennessee) was subcloned into the retroviral gene delivery vector (pLXSN-hAT1R-Flag). The hAT1R gene-containing virus was produced by co-transfecting HEK293 cells with three plasmids (pMD-G, pMD-gp and pLXSN-hAT1R-Flag) using the calcium phosphate method. The retrovirus-containing supernatant was harvested, centrifuged to remove cellular debris, and filtered. Podocytes cultivated under permissive conditions were infected by virus soup with 8 μg/ml polybrene then selected 4 days following viral transduction in geniticin (250 μg/ml; PAA, Cölbe, Germany) to obtain 100% positive cells.
Immunoprecipitation and Western blotting
For immunoprecipitation, cells were washed with ice-cold phosphate-buffered saline (PBS) and homogenized in ice-cold lysis buffer (12 mM Tris base, 8 mM HEPES, 50 mM NaCl, 15 mM KCl, 1.5 mM MgCl 2 , 1 mM EGTA, 10 mM Na 2 H 2 P 2 O 7 , 1 mM ATP, 20 mM NaF, 1 mM Na 3 VO 4 , 1% Triton X-100 and complete protease inhibitor [Roche]) on ice. Lysates were rested on ice for 30 min then centrifuged for 1 h at 16,000×g. Supernatants were pre-cleared by incubation with protein G-sepharose beads (Amersham Biosciences) coupled with actin antibody (sc-1616, Santa Cruz) for 6 h at 4°C on a rotary wheel. The pre-cleared protein extracts were then incubated with anti-Flag antibodyconjugated beads (M2 beads, Sigma-Aldrich) overnight at 4°C . The M2 beads were then washed twice in lysis buffer without NaF, Na 3 VO 4 , ATP, and Triton X-100. Precipitates were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and analyzed by immunoblotting of AT1R antibody (sc-1173, Santa Cruz). Pre-cleared protein extracts with equal volume were resolved by SDS-PAGE with subsequent β-tubulin antibody (sc-9104, Santa Cruz) immunoblotting to achieve total protein input control.
In conventional Western blotting, cultured podocytes or rat kidney tissues were washed with ice-cold PBS and homogenized in ice-cold lysis buffer on ice. Lysates were rested on ice for 30 min then centrifuged for 1 h at 16,000×g. Supernatant protein concentrations were measured using Advanced Protein Assay™ agents (ADV01, Cytoskeleton). Equal amounts of protein extract were resolved by SDS-PAGE and analyzed by immunoblotting of the Rac-1 (#610650, BD Biosciences), phospho-ezrin(Thr567)/radixin(Thr564)/moesin (Thr558) (#3141, Cell Signaling), ezrin/radixin/moesin (ERM) (#3142, Cell Signaling), α actinin-4 (#210-356, Alexis) or GAPDH antibodies (for loading control; ab9484, abcam). Chemiluminescent signals (LumiLight, Roche Diagnostics) were detected with a Lumi-Imager and quantified using the LumiAnalyst program (Roche Diagnostics).
Two-dimensional electrophoresis (2DE) followed by immunoblotting Cells were homogenized in 2DE lysis buffer (7 M Urea, 2 M Thiourea, 4% CHAPS, and 30 mM Tris) using a micro tissue grinder (model 440630, Radnoti) followed by three rounds of sonication (1 min) at 4°C. Lysates were rested on ice for 30 min then centrifuged for 1 h at 16,000×g. Protein concentrations of supernatants were determined as described above.
For 2DE, 11cm IPG Strips, pH 3-10 nonlinear (#163-2016, Bio-Rad) were rehydrated for 16 h as described in the ReadyStrip™ IPG Strip Instruction Manual. The first dimension separations were performed via cup loading with the PROTEAN IEF cell (Bio-Rad). For the second dimension electrophoresis, the focused IPG strips were equilibrated in a reduction buffer (37.5 mM Tris-HCl, pH 8.8, 6 M urea, 20% glycerol, 2% SDS, and 1% DTT) at 25°C for 15 min. The strips were then equilibrated in an alkylation buffer (37.5 mM Tris-HCl, pH 8.8, 6 M urea, 20% glycerol, 2% SDS, 0.002% bromophenol blue, and 2.5% iodoacetamide) at 25°C for 15 min. SDS-PAGE was performed in a 12% polyacrylamide gel cast in the Criterion 3 Cell (Bio-Rad). The separated proteins were immunoblotted with AT1R antibody. Chemiluminescent signals of AT1Rs and actin were quantitatively detected by Lumi-Imager.
Measuring intracellular Ca
2+ activity Intracellular Ca 2+ ([Ca 2+ ] i ) was measured by inverted fluorescence microscopy using the Ca 2+ -sensitive dye, Fura-2-acetomethyl ester (Molecular Probes) [15] . Podocytes were cultivated in collagen-coated coverslips and loaded with Fura-2-acetomethyl ester dye (5 μM, 45 min in room temperature). The coverslips were then placed in a microscope chamber with continuous fluid flow. ] i concentration was calculated using a fluorescence ratio of 340:380 nm according to the equation described by Grynkiewicz et al. [16] .
Rac-1, Cdc42, and RhoA activation assay An affinity precipitation assay for the activated Rac-1 and Cdc42 (Guanosine triphosphate (GTP)-bound state) was performed as instructed by the manufacturer (Rac1 activation assay biochem kit; BK035, Cytoskeleton). The assay used the p21-binding domain (PBD) of p21-activated kinase 1 (PAK), which specifically binds to the GTP-bound form of Rac and/or Cdc42. Briefly, stimulated AT1R podocytes were homogenized, and the lysates were promptly clarified by centrifuging for 5 min at 16,000×g, 4°C. The supernatants were added to 20 μl of GST-PAK PBD beads (20 μg protein), rotated for 60 min at 4°C, then the protein complexes were washed twice with wash buffer. Bound proteins were dissociated and denatured by heating in Laemmli buffer at 95°C for 5 min, subjected to SDS-PAGE (18%), and analyzed by immunoblotting of the Rac-1 antibody (ARC03, Cytoskeleton) or Cdc42 antibody (#2462, Cell Signaling). An affinity precipitation assay for activated RhoA using GST-tagged rhotekin-RBD (Rho binding domain of rhotekin) was performed as recommended by the manufacturer (BK036, Cytoskeleton) similarly to the Rac-1 activation assay.
Measuring NADPH oxidase activity and superoxide generation
Podocytes were double rinsed with ice-cold PBS, scraped with KREBS solution (containing 99 mM NaCl, 4.7 mM KCl, 1.8 mM CaCl 2 , 1.2 mM MgCl 2 , 25 mM NaHCO 3 , 1.03 mM K 2 HPO 4 , 20 mM Na-HEPES, and 11.1 mM glucose [pH 7.35]) and centrifuged (200×g, 4°C, 5 min). The supernatant was discarded, and the pellet resuspended in fresh KREBS buffer. The suspension was added to KREBS solution containing 5 μM lucigenin and stimulated with 100 μM nicotinamide adenine dinucleotide phosphate (NADPH). Bioluminescence was measured using a Lumat LB9501 (Berthold GmbH, Wildbad, Germany). Following measurement, cells were lysed and protein concentrations were measured. To calculate superoxide production, total counts were analyzed by integrating the area under the signal curve. The integrals were compared with a standard curve generated by xanthine/xanthine oxidase reaction as described elsewhere [17] . Superoxide generation was expressed as nanomoles of O 2 − generated per mg of cellular protein per minute (nmol O 2 − /mg protein/min). The xanthine/xanthine oxidase reaction also produced superoxide for podocyte stimulation.
Life cell imaging
Lamellipodium activities and membrane ruffles of individual podocytes were observed using time lapse video microscopy as described elsewhere [14] . Twelve hours before the experiments, the culture medium of the sparsely cultivated podocytes was switched for the vehicle medium (FBS-free and bicarbonate-free RPMI medium, pH 7.40), and the culture flasks were sealed. After adding Ang II (final concentration 100 nM) to the vehicle medium, the cell-containing culture flasks were resealed and placed in an electronically controlled heating chamber (37°C) on the stage of an inverted phase-contrast microscope (Axiovert 25, Zeiss). Images were recorded by time lapse video at 10-min intervals over 24 h and stored as stacks of Tiff-files.
Immunofluorescence and cortical F-actin score index Cells on coverslips were fixed in ice-cold trichloroacetic acid for 15 min (pERM and ERM protein staining), or PBS (α actinin-4 and F-actin staining) with 4% paraformaldehyde and 4% sucrose for 10 min. The cells were permeabilized in 0.1% Triton X-100 for 10 min, blocked in 10% BSA in PBS for 1 h and incubated with pERM antibody, ERM antibody or α actinin-4 antibody, with subsequent detection using fluorophore-conjugated secondary antibodies and/or phalloidin (Alexa Fluor® 488/594, Molecular Probes). Some cells were incubated briefly in 4′-6-Diamidino-2-phenylindole (DAPI, Molecular Probes) for nuclei visualization. Images were obtained using an inverted fluorescent microscope (Axiovert 100, Zeiss) and analytical software AxioVision (Zeiss). CFS index was determined based on at least three independent experiments. Cells were fixed and permeabilized, then stained with fluorophore-conjugated phalloidin and DAPI, as previously described. In each experiment, 12 low-magnification images (×400) were taken blindly from each group. All imaged cells were counted using DAPIstained nuclei and assessed as follows. The F-actin cytoskeletal reorganization for each cell was scored on a scale ranging from 0 to 3 based on the degree of cortical F-actin ring formation (score=0, no cortical F-actin, normal stress fibers; score=1, cortical F-actin deposits below 1/2 the cell border; score=2, cortical F-actin deposits exceeding 1/2 the cell border; score = 3, complete cortical ring formatting and/or total absence of central stress fiber. A minimum of 600 cells were examined in the 12 images from every group in each independent experiment, and the CFS index for Ang II or vehicle-treated podocytes is the average score of the counted cells±SEM.
Immunohistochemistry
Paraffin-embedded formalin-fixed 3-μm-thick kidney sections of Neph-hAT1R TGRs and littermates were deparaffinized, treated with 0.3% H 2 O 2 to block endogenous peroxidase and microwaved for two consecutive 10-min periods, at 500 W and 250 W, respectively. The sections were then incubated with a mouse monoclonal antibody to Rac-1 protein (#610650, BD Biosciences) or a polyclonal antibody to Wilms`tumor-1 protein (WT-1; sc-192, Santa Cruz) in a 1:50 dilution for periods of overnight (Rac-1) and 1 h (WT-1), respectively. Immunoperoxidase staining was performed as directed by the manufacturers of the Vecstain ABC kit (Vector laboratories). The immunoperoxidase staining was performed using diaminobenzidine (DAB; Sigma).
In vitro wound healing ('scratch') assay Twelve-well plates were pre-coated with type 1 collagen (#C3867, Sigma-Aldrich), and a sufficient number of AT1R podocytes were plated for them to become confluent in the wells immediately after differentiation (~14 days). Before creating the scratch wound, cells were FBS-starved for 24 h, then treated with Ang II (100 nM) and/or other inhibitors (losartan, PD123319, SCH51344, DMTU, Y27632) for another 24 h. The same areas of each well were then displaced by scratching a cross through the cell layer with a pipette tip. Floating cells were washed away with PBS. Medium containing 2.5% FBS was added to the wells and incubated for a further 48 h. Images of the scratched areas on each cross wound were photographed at 24 and 48 h using an inverted phase contrast microscope. Three independent experiments were performed, and 12 cross wounds were created for each group (n=12). To estimate cell migration, the number of cells crossing a 1-mm wound border was calculated at 48 h.
Statistical analyses
All data are represented as means±SEM unless otherwise specified. Group differences were tested by t-test. Comparisons involving more than two groups were performed by two-way ANOVA (SPSS, Chicago, IL, USA). The level of statistical significance was set to p<0.05.
Results
Establishment and characterization of a stable Ang II-responsive podocyte cell line
To identify the AT1R signaling mechanisms, human AT1R was stably expressed in a murine podocyte cell line [13] . Stable expression of human AT1R was verified by RT-PCR (data not shown), Flag-tag immunoprecipitation (Fig. 1a) and two-dimensional immunoblotting (Fig. 1b, left plot) . Retroviral transduction of human AT1R gene enables differentiated cultured podocytes to express more AT1R (2.72 ± 0.37-fold increase) than wild-type (WT) cells (Fig. 1b, right (Fig. 1d, lane 7) .
Effects of Ang II on ROS generation, dynamic cell morphology, and F-actin cytoskeleton in podocytes
Overproduction of reactive oxygen species (ROS) such as the superoxide anion (O 2 − ) and hydrogen peroxide has been detected in many experimental glomerulopathies. Growing evidence suggests that Ang II stimulates intracellular formation of ROS, and thus influences downstream signaling pathways [18] . Analysis of NADPH-dependent oxidase activity reveals that differentiated cultured AT1R podocytes pre-stimulated with Ang II (100 nM, 24 h) produced more O 2 − than those in the vehicle-treated group (Fig. 2a) . Losartan (200 nM) inhibited the ROS-activating effect of Ang II, indicating an AT1R-specific mechanism in podocyte.
The structural integrity of podocyte foot processes, particularly a stable F-actin cytoskeleton that maintains stability between cell-cell contacting slit diaphragm as well as the cell-matrix adhesion, is crucial for podocyte function [5] . Time lapse video microscopy and fluorescent phalloidin are used to examine whether Ang II modulates the morphology and F-actin cytoskeleton of AT1R podocytes. Life cell imaging revealed two morphologic phenotypes: dominant filopodium activity in vehicle-treated sparsely cultivated AT1R podocytes (Fig. 2b, panel i & ii) and increased lamellipodium activity and ruffled membranes in Ang II-stimulated cells under identical cultivation conditions (Fig. 2b, panel iii and iv) . The protrusion of lamellipodium or filopodium depends primarily on the organization of the cellular actin cytoskeleton. Staining the F-actin cytoskeleton with fluorophore-conjugated phalloidin-revealed characteristics of Ang II mediated cytoskeletal rearrangement in podocytes, including cortical F-actin ring formation and stress fiber attenuation (Fig. 2c) . In confluent cultivated podocytes with abundant inter-cell contacts, an identical Factin cytoskeletal reorganization to sparsely cultivated cells was observed following Ang II stimulation (Fig. 2d) .
Ang II signaling activates Rac-1 in cultured AT1R podocytes and up-regulates Rac-1 expression in glomeruli of Neph-hAT1 TGRs Small GTPase Rac-1 mediates Ang II-induced oxidative stress and myocardial hypertrophy [19] . This study examines whether Rac-1 is involved in podocyte Ang II signaling. Figure 3a shows that treating cultured AT1R podocytes with Ang II (100 nM, 24 h) activated Rac-1 (increase of GTPbound from). Pre-treatment with losartan, but not with Y27632 (Rho kinase inhibitor), inhibited this action of Ang II in activating Rac-1. Therefore, in podocytes, RhoA is not the upstream mediator of Ang II-induced Rac-1 activation. The activities of RhoA and Cdc42 in Ang II signaling were also examined. Early and transient RhoA activation was observed to be Rac-1 dependent (Fig. 3b, lane 1, 2, and 4-6) . Meanwhile, following 24 h of treatment, Ang II signaling significantly suppressed RhoA activity (Fig. 3b, lane 1 and  3) . However, no significant change in Cdc42 activity was detected in AT1R podocytes during the 24 h Ang IIstimulation period (data not shown). Figure 3c indicates that cytosolic Rac-1 expression increased after treating differentiated cultured AT1R podo- To determine whether Rac-1 influences the AT1R signaling of podocyte damage in vivo, its expression was examined in glomeruli and tubuli from 4-week-old podocyte-specific AT1R transgenic rats (Neph-hAT1 TGRs) and littermates [7] . At 4 weeks old, Neph-hAT1 TGRs and age-matched WT littermates are non-proteinuric and phenotypically indistinguishable. Figure 3d illustrates the results of Western blotting. Glomerular Rac-1 expression in Neph- Fig. 2 Effects of Ang II on ROS generation, dynamic cell morphology and F-actin cytoskeleton in AT1R podocytes. hAT1 TGRs was 1.62 times that of WT rats, while its expression was not considerably changed in tubuli of NephhAT1 TGRs. Immunohistochemistry Rac-1 staining of kidney sections from 4-week-old Neph-hAT1 TGRs and WT littermates exhibited similar results in glomerular tissues (Fig. 3e ).
Characterization and quantification of Rac-1 and ROS-mediated cell migration and podocyte cytoskeletal reorganization in AT1R signaling
The lamellipodia are found mainly in highly mobile cells. In this investigation, Ang II-treated podocytes displayed in-creased lamellipodium activity. Cell migration was assessed to test the hypothesis that Ang II induces a migratory phenotype in podocytes. An in vitro wound healing ('scratch') assay of confluent AT1R cells demonstrates that Ang II pre-treatment increases cell migration (Fig. 4a) . Losartan or SCH51344 (Rac-1 specific inhibitor) or DMTU (free radical scavenger) significantly attenuated Ang II-induced cell migration. Pretreating cells with PD123319 (AT2R specific inhibitor) and Y27632 (Rho kinase inhibitor) did not influence the Ang IImediated increase in cell migration (Fig. 4b) . Additionally, in the absence of Ang II, inhibitors (losartan, PD123319, SCH51344, DMTU, and Y27632) did not statistically significantly affect cell migration (data not shown).
A cortical F-actin score index (CFS index, see "Materials and methods") was designed to quantify the degree of cytoskeletal reorganization in cultured podocytes at varying concentrations of Ang II. Figure 5a illustrates the concentration-response curve for the effect of Ang II on the CFS index in AT1R podocytes. Like Ang II, ROS-induced concentration-dependent cytoskeletal changes in AT1R podocytes (Fig. 5b) . The inhibitory effects of losartan, DMTU, and SCH51344 on Ang II-induced change in CFS index indicated that AT1R, ROS, and Rac-1 mediated Ang II-induced cytoskeletal reorganization of podocytes (Fig. 5c ).
Rac-1 mediates Ang II-induced ezrin/radixin/moesin protein phosphorylation resulting in F-actin cytoskeletal reorganization
Ezrin/radixin/moesin proteins are crucial links between cortical F-actin cytoskeleton and membrane proteins on cell peripheries [20] . To elucidate how ERM proteins affect AT1R signaling pathways and induce cytoskeletal reorganization, Ang II-stimulated cultured AT1R podocytes were examined via immunofluorescent staining and immunoblotting. Ang II induced threonine phosphorylation of ERM proteins and phosphorylated ERM (pERM) proteins localized especially at the periphery of AT1R podocytes (Fig. 6a, i and ii) . The Rac-1 inhibitor SCH51344 inhibited the action of Ang II on ERM protein phosphorylation, indicating that cortically distributed pERM proteins are the downstream effecters of Rac-1 and mediate F-actin reorganization in AT1R signaling (Fig. 6a, iii) . ERM protein staining reveals a constant distribution before and after Ang II treatment (Fig. 6a, iv-vi) .
Immunoblotting confirmed that AT1R mediates Ang IIinduced ERM protein phosphorylation (Fig. 6b) . Ang II- Fig. S1 a-d . e Immunohistochemical staining with antibodies to Rac-1 in glomeruli of 4-week-old Neph-hAT1TGR (i) and WT littermate (ii). Rac-1 staining was observed to increase in a podocyte pattern. Immunohistochemical staining using antibodies to Wilms`tumor-1 protein as a podocyte marker was performed to provide a comparison (iii) TGR kidney staining without primary antibody was performed to provide a negative control (iv). Magnification, ×40
induced ERM protein phosphorylation was inhibited by losartan, SCH51344, and DMTU, suggesting that AT1R, Rac-1 activation, and ROS production are crucial to the process of phosphorylation. The in vitro Ang II signaling mechanism was also confirmed by the in vivo animal model used in this study. Regarding glomeruli of 4-week- AT1R podocytes (a-c) . The degree of F-actin cytoskeletal reorganization for each individual cell was assessed on a scale of 0 to 3 based on degree of cortical F-actin formation. A minimum of three independent experiments were performed (n=3), and over 600 cells were scored for every group. The CFS index for Ang II-or vehicletreated podocytes is presented as an average score for cells counted± SEM. c Regarding Ang II-induced change of CFS index, the inhibitory effects of losartan, DMTU and SCH51344, but not Y27632, indicated that Ang II-mediated cytoskeletal reorganization in podocytes was mediated by AT1 receptor, ROS and Rac-1. (Ang II, 100 nM; losartan, 200 nM; PD123319, 200 nM; DMTU, 10 mM; SCH51344, 10 μM; Y27632, 5 μM) Fig. 6 Rac-1 mediates Ang IIinduced ezrin/radixin/moesin protein phosphorylation leading to F-actin cytoskeletal reorganization. a Immunostaining was used to examine the expression and distribution of pERM and ERM proteins in cultured AT1R podocytes (Ang II old Neph-hAT1 TGRs, immunoblotting revealed that both total and phosphorylated ERM proteins increased compared to age-matched WT littermates (Fig. 6c) .
Examining the effects of different serine/threonine kinase inhibitors on ERM protein phosphorylation elucidated the signaling effector mechanisms leading to ERM phosphorylation by Ang II. Heparin (potent G protein-coupled receptor kinase 2 [GRK2] inhibitor) abated ERM protein phosphorylation in Ang II-treated podocytes (Fig. 6d) , while Y27632 (Rho kinase inhibitor), SB203580 (p38 MAPK inhibitor) and calphostin C (pan protein kinase C inhibitor) did not. Moreover, heparin inhibited the effect of Ang II on F-actin cytoskeletal reorganization of cultured AT1R podocytes, which was hypothetically mediated by ERM protein phosphorylation (Fig. 6e) .
α actinin-4 is down-regulated in Neph-hAT1 TGR glomeruli and Ang II-treated cultured podocytes α actinin-4, encoded by the FSGS gene ACTN4 [21] , acts as an actin bundle cross-linker, which is necessary for normal podocyte adhesion [22] . To further explore the mechanisms linking sustained podocyte F-actin cytoskeletal reorganization to proteinuria and podocyte depletion developed from the Neph-hAT1 TGR model, this study examined expression levels of expression levels of α actinin-4 in Neph-hAT1 TGRs (Fig. 7a) . Glomerular expression of α actinin-4 approximately doubled in 4-week-old Neph-hAT1 TGRs than in age-matched WT littermates (Fig. 7b, left  plot) . Subsequently, reduced glomerular expression of α actinin-4 was detected in 15-week-old Neph-hAT1 TGRs, which displayed proteinuria (Fig. 7b, right plot) . Expression of α actinin-4 was also down-regulated in cultured AT1R podocyte following 24 h Ang II treatment (Fig. 7c,d) . SCH51344, Y27632 and heparin (used to inhibit F-actin cytoskeletal reorganization), eliminated the effects of Ang II on α actinin-4 expression in AT1R podocytes, while SB203580 and calphostin C did not, suggesting that Rac-1, RhoA, and F-actin cytoskeletal reorganization regulate α actinin-4 expression, but P38 MAPK and protein kinase C do not. Double immunostaining revealed that α actinin-4 staining of vehicle-treated podocytes was confined to F-actin stress fibers (indicated by arrows) and focal adhesions (indicated by arrow heads) at the ends of stress fibers (Fig. 7e) . Ang II treatment induced reduced α actinin-4 staining, down-regulation of focal adhesions and redistribution of α actinin-4 to the periphery of cells as focal complexes (indicated by stars). Like the cell morphologic and migration assay data, results from α actinin-4 and Factin double immunostaining suggest that Ang II induced a phenotypic change, shifting from a dynamic stable state (focal adhesions associated with F-actin stress fibers) to a migratory state (focal complexes associated with membrane ruffles).
Discussion
This study investigated the mechanisms through which Ang II affects the cytoskeleton of podocytes by using a new cultured murine podocyte model that stably expresses functional human AT1Rs. Although the components of the RAS (angiotensinogen, renin, ACE type 1, AT1R, and AT2R) has been characterized in immortalized human cultured podocytes [23] , only a fraction of these cells respond to Ang II with increased [Ca 2+ ] i . Culturing cells outgrowing from sieved glomeruli can yield primary podocytes that ex vivo respond well to Ang II; however, limited cell numbers and mesangial cell contamination impede further signaling investigations and large-scale proteomic study. Retroviral-mediated stable transduction of human AT1R to a well-characterized immortalized murine podocyte cell line can resolve these problems. While less robust than transient tranfection methods, the expression level of AT1R in podocytes was 2.7 times that in empty vector transducted or WT cells. Similar to podocytes in vivo [3, 4] , differentiated AT1R podocytes responded to nanomolar concentrations of Ang II with significantly increased [Ca 2+ ] i . Additionally, the AT1R podocyte has all the characteristics of the origin cells, including dominant Factin stress fiber formation, stable expression of nephrin and abundant cell-cell contact, and also possesses several characteristics of in situ podocyte interdigitating foot processes. Consequently, the combination of Neph-hAT1 TGRs and the AT1R podocyte cell line represents an experimental system for examining Ang II signaling mechanisms that includes both in vitro and in vivo models.
This work demonstrates that AT1R signaling promotes augmented ROS production, increased lamellipodia and membrane ruffle activity, ROS-mediated F-actin cytoskeletal reorganization and a migratory phenotype of podocytes. The small GTPase Rac-1 dominates these Ang II effects on podocyte cytoskeleton. Additionally, Rac-1 is a crucial component of NADPH oxidase, which mediates Ang II-induced ROS production [18] . Furthermore, Rac-1 expression is increased in AT1R podocytes both after Ang II stimulation and during the early stage of podocyte injury in Neph-hAT1 TGRs. These experimental findings indicate that glomerular Rac-1 is likely pivotal in the development of proteinuria and FSGS in response to Ang II. RhoA is only transiently activated in an AT1R-mediated and Rac-1-dependent manner. Sustained 24 h Ang II stimulation activates Rac-1 and significantly suppresses RhoA activity of AT1R podocytes compared to the untreated cells. This suppression is unsurprising because sustained Rac-1 acti-vation increases intracellular production of ROS, which is a well-known suppressor of RhoA activity. Nevertheless, Cdc42 activity remains unchanged regardless of Ang II stimulation. The above findings from Rho subfamily GTPases activity assay are closely correlated with our observations regarding podocyte cytoskeletal changes. Rac-1, but not RhoA, dominates the Ang II-induced ROSpERM-cortical actin ring effector axis of podocytes.
Suppression of Rho activity in cultured AT1R podocytes with an efficient ROCK inhibitor (Y27632) cannot eliminate Ang II-induced ERM phosphorylation, cortical F-actin ring formation and cell migration even when the cell shapes are significantly changed. Because Rac-1 conducts Ang II signaling in podocytes, Rac-1 inhibitors provide a potential therapeutic target for protecting podocytes from excess ROS generation and cytoskeletal rearrangement. Lining the outer aspect of the capillary loop, podocytes counteract the extension forces from hydraulic glomerular filtration. To adapt to variable filtration forces resulting from blood pressure change and retain glomerular capillary loops with a constant size and shape, the F-actin cytoskeleton of podocyte foot processes requires considerable plasticity. Ang II-induced cytoskeletal reorganization may be a physiological plasticity of podocyte to counteract the increasing distension of the capillary wall and cover the enlarged capillary surfaces induced by intraglomerular local RAS activation [24] . Because the actin-based cytoskeletal network in podocyte foot processes is linked to the basement membrane and slit diaphragm via different adaptor molecules, sustained or major change of the F-actin cytoskeleton in foot processes tends to impair podocyte stability, in turn impairing the structure and function of the filtration barrier, eventually causing proteinuria. Indeed, sustained AT1R activation may lead to excess ROS production, cellular oxidative stress, actin-binding molecule exhaustion, reduced podocyte adhesion, and podocyte depletion, all of which can cause proteinuria. Hypothesis originating from continuous Ang II signaling on the cytoskeleton and leading to podocyte injury can improve mechanistic understanding of the benefits of RAS blockage for proteinuria reduction in patients with chronic renal disease.
Ezrin bridges the cytoplasmic part of podocalyxin and the actin cytoskeleton through Na + /H + -exchanger regulatory factor 2 (NHERF2) in the apical domain of podocyte foot processes [25] . Disruption of the podocalyxin/ NHERF2/ezrin complex is supposed to lose podocyte surface negative charge and influence foot process morphology and slit diaphragm stability [26] . The process by which adapter molecules of the ezrin/radixin/moesin family target the F-actin cytoskeleton in podocyte injury is poorly understood. Phosphorylation regulates the structural changes between the dormant and active conformations of ERM proteins [20] . Following activation, phosphorylated ERM proteins generate associations with plasma membrane proteins and form abundant F-actin-membrane linkages. Tumor necrosis factor-α-induced ERM phosphorylation in cultured endothelial cells was accompanied by cytoskeletal changes, paracellular gap formation, and increased permeability to fluxes of dextran and albumin [27] . Phosphorylated ERM proteins, which may indicate high F-actin turnover, are increased in Ang II-stimulated cultured podocytes and glomerular extracts of Neph-hAT1 TGRs. Both AT1R blocker and Rac-1 specific inhibitor, but not Rho kinase inhibitor, have been demonstrated to inhibit Ang II-induced F-actin cytoskeletal reorganization and ERM protein phosphorylation of cultured AT1R podocyte, indicating that, unlike studies of other cell types [28] [29] [30] , RhoA signaling pathway is not the dominant mediator of ERM protein phosphorylation in podocytes.
The downstream kinase effector in podocytes was elucidated by inhibiting serine/threonine kinases that reportedly use ERM proteins as a substrate (namely, Rho kinase [28, 29] , p38 MAPK [27, 31] , G protein-coupled receptor kinase 2 [32] , and protein kinase C [27, 33] ). The data indicate that Rho kinase, p38 MAPK and protein kinase C do not phosphorylate ERM proteins in AT1R signaling of podocytes. Notably, heparin, which is known to alleviate proteinuric renal disease [34] , effectively eliminated Ang II-induced ERM protein phosphorylation and subsequently prevented the rearrangement of podocyte F-actin cytoskeleton. Heparin is a known potent inhibitor of G protein-coupled receptor kinase 2 (GRK2) [35] . Additionally, a recent study has shown that ezrin is a novel substrate of GRK2-mediating membrane ruffles in Hep2 cells [32] . Heparin thus may exert glomerular protection effects on podocyte cytoskeleton by inhibiting GRK2-mediated ERM protein phosphorylation.
Mutations in human α actinin-4 gene cause autosomal dominant proteinuric kidney disease [21] . Mice deficient in α actinin-4 develop a recessive phenotype characterized by kidney failure, proteinuria, retraction of glomerular podocyte foot processes and FSGS [36] . Both in vivo models exhibit nephron degenerated pathways with slowly progressive proteinuria and late onset glomerulosclerosis, likely caused by impaired podocyte cytoskeleton function. Cross-linking of actin filament bundles by α actinin-4 is necessary for normal podocyte adhesion [22] . Notably, α actinin-4 interacts with integrins and enhances podocyte-matrix interaction, stabilizing glomerular architecture and preventing podocyte detachment. The effects of α actinin-4 on Ang II-related actin cytoskeletal change in podocytes are poorly understood. However, this work demonstrated that α actinin-4 expression is down-regulated in cultivated Ang II-treated podocytes. Moreover, this investigation identified a correlation between decreased glomerular α actinin-4 expression and proteinuria development. Furthermore, this study found that Rac-1, RhoA, and ERM protein phosphorylation mediated Ang IIinduced α actinin-4 down-regulation of podocytes, indicating high turnover of F-actin cytoskeleton. Sustained Ang II signaling in podocytes, involving repeated depolymerization and polymerization of G-actins, and consuming numerous actin adaptor or cross-linking proteins, thus may exhaust α actinin-4 expression and reduce podocyte-matrix adhesion. Detachment of podocytes from the glomerular basement membrane causes gradual podocyte depletion, and eventually FSGS. In contrast to the regulation of F-actin cytoskeleton, which is dominated by the Rac-1 effect, Rac-1 and RhoA are both necessary in Ang II-associated expression regulation of α actinin-4. The experimental results presented here demonstrate these dual activating effects of Rac-1 and RhoA signaling ("Rac and Rho" effect).
In vascular smooth muscle cells, Ang II activates NADPH oxidase and Rac-1 with increased intracellular Ca 2+ in a protein kinase C (PKC)-dependent manner [37, 38] . This work identified a PKC-independent AT1R signaling pathway for Rac-1 activation in podocyte cytoskeletal reorganization. By using a sufficient concentration of pan-PKC inhibitors, calphostin C and tamoxifen (data not shown), PKC inhibition did not eliminate Ang II effects on Rac-1-mediated ERM phosphorylation and α actinin-4 down-regulation in cultured podocytes. Although ERM proteins are potential PKC substrates in several cell types [27, 33] , the experimental results presented here are consistent with a recent in vitro study demonstrating that PKC activation suppressed phosphorylation of ezrin and moesin in carcinosarcoma cells [39] . One recent investigation demonstrated that ADPribosylation factor 6 (ARF6) and Rac-1 are sequentially activated following stimulation of Ang II [40] . Following receptor activation, ARF6 and Rac-1 transiently form a complex, which then induces AT1R expressing HEK293 cells to ruffle, form membranous protrusions, and migrate in response to agonist treatment. These experimental results suggest that a novel PKC-independent Rac-1 activating mechanism in AT1R signaling causes actin remodeling.
To summarize, this study demonstrated that Ang IIinduced signaling activates Rac-1, ROS, and the heparininhibitable phosphorylation of ERM proteins in podocytes (Fig. 8) . Ang II signaling leads to rearrangement of cortical F-actin, stress fiber attenuation, down-regulation of α actinin-4 and a switch to a migratory phenotype. Podocytes shifting from the dynamically stable to the adaptively migratory phenotype exhibit increased actin turnover and more ROS from AT1R signaling in response to physiological stress or injury. Chronically activated AT1R may deplete podocytes and subsequently cause FSGS. The data presented in this study also suggest that heparin and Rac-1 inhibitors have therapeutic potential for podocyte injury.
